These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1957225)

  • 1. [Treatment of hormone-dependent neoplasms (prostatic cancer, breast cancer). The place of LH-RH analogs].
    Charron M
    Soins; 1991 Sep; (552):61-4. PubMed ID: 1957225
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers.
    Redding TW; Schally AV
    Prog Clin Biol Res; 1988; 262():217-40. PubMed ID: 2897695
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
    Schally AV; Redding TW; Comaru-Schally AM
    Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [LHRH analogs as monthly depot preparations in treatment of advanced prostate cancer].
    Urologe A; 1991 May; 30(3 Suppl):2-3. PubMed ID: 1746071
    [No Abstract]   [Full Text] [Related]  

  • 5. [History of clinical studies on hypothalamic hormone analogs in Mexico].
    Schally AV; González Bárcena D
    Gac Med Mex; 2006; 142(4):315-25. PubMed ID: 17022307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [LHRH analogs--a new treatment in hormone-dependent tumors].
    Wilking N; Rutqvist LE; Theve T
    Lakartidningen; 1988 Feb; 85(8):620-3. PubMed ID: 3280927
    [No Abstract]   [Full Text] [Related]  

  • 7. [The LH-RH analogs. Drug treatment of prostate cancer].
    Gerson C
    Soins; 1995 Nov; (600):61-2. PubMed ID: 8715119
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth inhibitory effect of LH-RH analogs on human breast cancer cells.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Gaggini C; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(1):187-90. PubMed ID: 2965864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic hormones and cancer.
    Schally AV; Comaru-Schally AM; Nagy A; Kovacs M; Szepeshazi K; Plonowski A; Varga JL; Halmos G
    Front Neuroendocrinol; 2001 Oct; 22(4):248-91. PubMed ID: 11587553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete androgen blockade for the treatment of prostate cancer.
    Labrie F; Dupont A; Belanger A
    Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gonadotropin-releasing hormone analogues in the treatment of metastatic breast carcinoma].
    Nesković-Konstantinović Z; Radulović S; Vuletić L
    Srp Arh Celok Lek; 1993; 121(1-2):33-5. PubMed ID: 8202820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH].
    Bertelli A
    Drugs Exp Clin Res; 1990; 16 Suppl():1-2. PubMed ID: 2081448
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of prostatic cancer with slow-release formulation of luteinizing hormone releasing hormone (LH-RH) analog].
    Fuse H; Akimoto S; Akakura K; Shimazaki J; Murakami S
    Hinyokika Kiyo; 1988 Mar; 34(3):555-60. PubMed ID: 3133936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian ablation as treatment for young women with breast cancer.
    Davidson NE
    J Natl Cancer Inst Monogr; 1994; (16):95-9. PubMed ID: 7528032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
    Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
    Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
    Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin].
    Schally AV
    An R Acad Nac Med (Madr); 2004; 121(3):493-500. PubMed ID: 15751842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal treatment of advanced disease: some newer aspects.
    Griffiths K; Eaton CL; Harper ME; Turkes A; Peeling WB
    Semin Oncol; 1994 Oct; 21(5):672-87. PubMed ID: 7939755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.